Command Palette
Search for a command to run...
PARP1-mediated PARylation of SPRTN restrains its DNA-protein crosslink repair activity
Rahman, A.; Quevedo, V.; Garcia, M.; Rhiner, A.; Simonson, Q.; Perez, E.; Lopez-Mosqueda, J.
PARP1-dependent PARylation of SPRTN acts as negative feedback restraining SPRTN DNA engagement and proteolytic activity, positioning PARP1 as an upstream regulator of DNA-protein crosslink repair and of TOP1 cleavage-complex clearance.
Moderate contradiction
2 prior failuresTwo documented clinical failures match this mechanism, or a single Phase 3 failure is on record.
Abstract excerpt
SPRTN is a DNA-dependent metalloprotease that resolves DNA-protein crosslinks, but how its activity is restrained on chromatin remains unclear. Here we show that SPRTN is PARylated in a PARP1- and HPF1-dependent manner. Mass spectrometry datasets identify seven modified residues in the C-terminal region, and substituting them (SPRTN-PARless) strongly reduces PARylation. The Nudix homology domain is required for SPRTN to interact with PARP1 and for efficient PARylation. SPRTN-PARless accumulates faster and to higher levels at laser-induced DNA damage than wild-type SPRTN. PARylation reduces single-stranded DNA binding of both cell-derived and purified SPRTN, and PARG treatment reverses this effect for cell-derived protein. SPRTN-PARless shows increased autocleavage and accelerates clearance of camptotheci-induced TOP1 cleavage complexes. These findings suggest that PARylation acts as negative feedback on SPRTN after its PAR-dependent recruitment, restraining its DNA engagement and proteolytic activity.
Matching Claidex post-mortems
2 of 2 indexed- Sep 21, 2026KEYLYNK-009: olaparib maintenance in unselected metastatic TNBC matched chemotherapy but never beat itOlaparib (Lynparza, AZD2281) plus pembrolizumabEfficacyMRS 56
- Aug 29, 2026Talazoparib plus temozolomide in DNA-repair wild-type prostate cancer: toxicity scaled, response did notTalazoparib plus temozolomideTranslational MismatchMRS 56
This is an automated contradiction flag, not an editorial judgment on the preprint's quality. Flags identify where the preclinical literature and the clinical failure record diverge.

